DEFINITIVE NOTICE AND PROXY STATEMENT

Company

GYRE THERAPEUTICS, INC.

Filed

April 17, 2013

Period of Report

May 31, 2013

Accession Number

0001193125-13-158327

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →